Abbott Laboratories (Pakistan) Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PK0025701019
PKR
994.67
55.02 (5.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
17,346.45
18,613.12
17,364.55
16,170.60
16,028.93
14,250.18
13,981.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
17,346.45
18,613.12
17,364.55
16,170.60
16,028.93
14,250.18
13,981.91
Raw Material Cost
11,652.71
13,162.85
11,782.03
12,350.67
11,677.56
10,819.24
11,512.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.95
5.03
5.99
5.94
6.66
6.27
7.09
Selling and Distribution Expenses
3,052.66
2,473.12
2,715.32
2,621.58
2,681.17
2,090.04
2,310.69
Other Expenses
2.38
1.38
2.45
0.71
1.21
0.89
-0.71
Total Expenditure (Excl Depreciation)
14,733.16
15,654.75
14,527.87
14,985.25
14,377.48
12,924.42
13,823.08
Operating Profit (PBDIT) excl Other Income
2613.2999999999997
2958.3999999999996
2836.7000000000003
1185.4
1651.5
1325.8000000000002
158.8
Other Income
205.76
165.93
83.00
198.49
244.38
361.41
188.40
Operating Profit (PBDIT)
3,179.68
3,443.87
3,305.90
1,714.12
2,295.91
2,038.57
740.38
Interest
3.95
5.03
5.99
5.94
6.66
6.27
7.09
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.37
-0.37
Gross Profit (PBDT)
5,693.74
5,450.27
5,582.52
3,819.94
4,351.37
3,430.95
2,469.53
Depreciation
447.44
453.12
448.11
446.09
433.14
412.65
403.15
Profit Before Tax
2,728.29
2,985.73
2,851.81
1,262.09
1,856.11
1,620.01
329.77
Tax
1,128.62
1,700.78
1,042.66
640.71
337.35
565.54
323.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,599.67
1,284.95
1,809.14
621.38
1,518.76
1,054.47
6.67
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,599.67
1,284.95
1,809.14
621.38
1,518.76
1,054.47
6.67
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,599.67
1,284.95
1,809.14
621.38
1,518.76
1,054.47
6.67
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
24,418.58
23,724.64
22,431.58
20,541.11
19,838.59
18,237.35
16,517.59
Earnings per share (EPS)
16.34
13.13
18.48
6.35
15.51
10.77
0.07
Diluted Earnings per share
16.34
13.13
18.48
6.35
15.51
10.77
0.07
Operating Profit Margin (Excl OI)
14.56%
15.18%
15.98%
6.61%
10.1%
8.87%
1.06%
Gross Profit Margin
18.31%
18.48%
19.0%
10.56%
14.28%
14.26%
5.24%
PAT Margin
9.22%
6.9%
10.42%
3.84%
9.48%
7.4%
0.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2025 is -6.80% vs 7.19% in Dec 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2025 is 24.49% vs -28.97% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2025 is -9.27% vs 1.71% in Dec 2024

stock-summary

Interest

QoQ Growth in quarter ended Mar 2025 is -22.00% vs -16.67% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024

Compare Quarterly Results Of Abbott Laboratories (Pakistan) Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(PKR)
Change(%)
Net Sales
17,346.45
15,580.14
1,766.31
11.34%
Other Operating Income
0.00
0.00
0.00
Total Operating income
17,346.45
15,580.14
1,766.31
11.34%
Raw Material Cost
11,652.71
10,254.25
1,398.46
13.64%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.95
114.10
-110.15
-96.54%
Selling and Distribution Expenses
3,052.66
1,602.37
1,450.29
90.51%
Other Expenses
2.38
-11.41
13.79
120.86%
Total Expenditure (Excl Depreciation)
14,733.16
11,856.62
2,876.54
24.26%
Operating Profit (PBDIT) excl Other Income
2,613.29
3,723.52
-1,110.23
-29.82%
Other Income
205.76
-109.53
315.29
287.86%
Operating Profit (PBDIT)
3,179.68
3,953.59
-773.91
-19.57%
Interest
3.95
114.10
-110.15
-96.54%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
5,693.74
5,325.89
367.85
6.91%
Depreciation
447.44
319.44
128.00
40.07%
Profit Before Tax
2,728.29
3,520.05
-791.76
-22.49%
Tax
1,128.62
1,393.50
-264.88
-19.01%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,599.67
2,126.55
-526.88
-24.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,599.67
2,126.55
-526.88
-24.78%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,599.67
2,126.55
-526.88
-24.78%
Equity Capital
0
0
0.00
Face Value
10.00
10.00
0.00
Reserves
24,418.58
30,403.09
-5,984.51
-19.68%
Earnings per share (EPS)
16.34
6.68
9.66
144.61%
Diluted Earnings per share
16.34
6.68
9.66
144.61%
Operating Profit Margin (Excl OI)
14.56%
24.03%
0.00
-9.47%
Gross Profit Margin
18.31%
24.64%
0.00
-6.33%
PAT Margin
9.22%
13.65%
0.00
-4.43%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,734.65 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -6.80% vs 7.19% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 8.22% vs 16.10% in Mar 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 159.97 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 24.49% vs -28.97% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 5.33% vs 791.94% in Mar 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 297.39 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -9.27% vs 1.71% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 44.96% vs 64.09% in Mar 2024

Quarterly - Interest
Interest 0.39 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -22.00% vs -16.67% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -41.79% vs -26.37% in Mar 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.56%
in Mar 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 has improved from Mar 2024